Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

457 studies match

clinicaltrialsPublishedShowing 51–100 of 457 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02519348	A Study of Durvalumab or Tremelimumab Monotherapy, or Durvalumab in Combination With Tremelimumab or Bevacizumab in Advanced Hepatocellular Carcinoma	active not recruiting	Phase 2	433	MedImmune LLCINDUSTRY	9	Aug 5, 2026	clinicaltrials
NCT06706076	A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations(SOLARA)	recruiting	Phase 1 / Phase 2	675	BlossomHill TherapeuticsINDUSTRY	9	Aug 5, 2026